Mark G. Allen is listed as an executive officer and director on 9 SEC Form D filings by 3 issuers between Apr 2009 and May 2012: CARDIOMEMS INC (Atlanta, GA — other health care — 2009–2010; $60M reported sold to 94 investors), Axion BioSystems, Inc. (Atlanta, GA — biotechnology — 2009–2012; $8M reported sold to 31 investors) and Icon Medical Corp (Atlanta, GA — other health care — 2012; $2.7M reported sold to 23 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as executive officer and director, over about 3 years. Across those companies the filings report $70.7M sold in total.
Listed alongside Jay S. Yadav (6 shared filings), Marvin L. Woodall (6 shared filings), Daniel H. Bauer (5 shared filings), David R. Stern (5 shared filings), John Huntz, Jr. (5 shared filings) and 17 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Mark. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 1 SEC release, 7 bankruptcy cases matching the name listed in Key records below.
What this means 8 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 9 public filings for Mark G. Allen and found 12 differences, 1 worth asking the sponsor about: Form D filed 81 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.